Skip to main content
Upload a folder of clinical trial papers and ask Anara to analyze every one and produce a comprehensive study guide: pharmacologic approach, trial designs, primary and secondary endpoints with statistics, adverse event profiles, evidence limitations, and clinical implications. For medical affairs, clinical pharmacy, and MedComms professionals who need complete coverage, not summaries.

​
1. Describe the task

A standard summary gives you the headline findings. Your job requires the complete picture: every primary and secondary endpoint with the reported statistics, every significant adverse event, every study design limitation that a regulatory reviewer or a prescriber will ask about. Anara can read every paper in a folder and produce a comprehensive clinical study guide that does not compress or skip. You set ground rules at the start of the session: only use the provided materials, do not miss anything, give me all the statistics. Anara works through the folder and returns a guide covering pharmacologic rationale, key trial designs, primary and secondary efficacy outcomes with confidence intervals and p-values, adverse event profiles, limitations of the evidence, and clinical implications. The output feeds directly into an MSL preparation brief, a medical affairs evidence package, or a clinical pharmacy review. This is not a summary for a non-specialist audience. It is the document that a specialist reads before a formulary presentation, an evidence review board, or a journal club where every number is fair game for scrutiny. Here a clinical pharmacy faculty member at a major US university has a folder of trials on combination antibiotic therapy and needs a study guide that covers every trial in full depth. 
Before proceeding, establish these ground rules: from this point forward, all responses must be based exclusively on the materials in my folder. Do not use external knowledge or supplement with information not present in these documents.

Deeply analyze every PDF in the folder "Triple Antibiotic Therapy Trials." Give me a comprehensive clinical study guide covering:
1. Pharmacologic rationale for triple therapy versus standard of care
2. Key trial designs: phase, patient population, inclusion and exclusion criteria, comparators
3. Primary endpoints: measure, reported result, confidence interval, p-value for each trial
4. Secondary endpoints: all reported, with statistics
5. Adverse event profiles: rates, severity grading, discontinuations due to AE
6. Limitations of the evidence base as reported by the study authors
7. Clinical implications and where the evidence is insufficient or conflicting

Do not miss anything. If I feel you are missing data, I will ask you to go back.

​
2. Give Anara context

Required context
  • A folder containing the clinical trial publications you want analyzed.
Optional context
  • The clinical question or formulary decision the study guide is supporting. Anara weights the evidence depth toward the dimensions most relevant to that decision.
  • A target therapeutic area context (oncology, infectious disease, cardiology). Helps Anara use the correct clinical vocabulary for endpoints and safety reporting.

​
3. What Anara creates

A comprehensive, cited study guide covering every paper in the folder. Each trial gets its own section. Each endpoint is reported with its full statistics as stated in the paper. Adverse event data is organized by frequency and severity. Where the evidence base is insufficient or conflicting, those gaps are named explicitly rather than smoothed over. The guide is the single document you read before any clinical presentation, evidence board, or MSL field conversation where the details matter.

​
4. Follow-up prompts

​
Ask for deeper statistics on one endpoint

When the summary table is not enough and you need the full statistical picture for a specific outcome. 
Go back to the first two trials in the folder. For the primary endpoint only, give me the complete statistical picture: the reported effect size, the confidence interval, the p-value, the number needed to treat where reported, and any subgroup analysis that appeared in the paper.

​
Identify where the evidence conflicts

When you need to understand where the trials disagree before a formulary presentation. 
Across all trials in the folder, identify every outcome measure where the studies report conflicting results. For each conflict, name the trials, the reported values, and any methodological difference that might explain the discrepancy.

​
Write the clinical summary for a formulary submission

When the study guide is complete and you need a condensed version for a formal submission. 
Write a 400-word clinical evidence summary suitable for a formulary submission. Cover the strength of the evidence base, the primary efficacy outcomes, the significant safety signals, and the main limitations. Cite the specific trials for every claim.

​
5. Tricks, tips, and troubleshooting

​
How you word your prompt shapes what you get

Setting explicit ground rules at the start of the session (“all responses must be based exclusively on the provided materials”) is the most important prompt-craft move in this workflow. Without it, Anara synthesizes across its general clinical knowledge alongside your papers, which produces responses that are harder to audit and may not match the specific trial populations you are analyzing. If the study guide feels compressed on a section, say so directly: “I feel like you are missing data in the adverse event section. Go back and extract it more completely.” Users who get the best results from this workflow treat the first pass as a draft they interrogate, not a final product.

​
Check the output against your own understanding

Adverse event data is the section most likely to be compressed, especially when papers report it across multiple tables and appendices. Before presenting AE rates from the study guide to a clinical audience, cross-check the reported numbers against the source paper’s safety tables. p-values and confidence intervals can also be misread if a paper presents both unadjusted and adjusted values. The source papers remain the primary record; the study guide is the organized navigation layer.

​
What to do with the output next

Save the study guide as a note in Anara and use it as your reference document for MSL briefs, medical affairs evidence packages, and journal club preparation. When new trials are published in the same therapeutic area, import them to the folder and ask Anara to update the relevant sections of the guide rather than regenerating it in full. Use the clinical summary follow-up to produce a condensed version for regulatory or payer submissions.